KETOCONAZOLE tablet

Valsts: Amerikas Savienotās Valstis

Valoda: angļu

Klimata pārmaiņas: NLM (National Library of Medicine)

Aktīvā sastāvdaļa:

KETOCONAZOLE (UNII: R9400W927I) (KETOCONAZOLE - UNII:R9400W927I)

Pieejams no:

Aidarex Pharmaceuticals LLC

SNN (starptautisko nepatentēto nosaukumu):

KETOCONAZOLE

Kompozīcija:

KETOCONAZOLE 200 mg

Ievadīšanas:

ORAL

Receptes veids:

PRESCRIPTION DRUG

Ārstēšanas norādes:

Ketoconazole tablets USP, 200 mg should be used only when other effective antifungal therapy is not available or tolerated and the potential benefits are considered to outweigh the potential risks. Ketoconazole tablets USP, 200 mg are indicated for the treatment of the following systemic fungal infections in patients who have failed or who are intolerant to other therapies: blastomycosis, coccidioidomycosis, histoplasmosis, chromomycosis, and paracoccidioidomycosis. Ketoconazole tablets USP, 200 mg should not be used for fungal meningitis because it penetrates poorly into the cerebrospinal fluid. Coadministration of a number of CYP3A4 substrates is contraindicated with ketoconazole tablets. Coadministration with ketoconazole can cause elevated plasma concentrations of these drugs and may increase or prolong both therapeutic and adverse effects. For example, increased plasma concentrations of some of these drugs can lead to QT prolongation and ventricular tachyarrhythmias including occurrences of torsades de p

Produktu pārskats:

Ketoconazole tablets USP, 200 mg are white to off-white round, flat tablets, one side scored and engraved with "T" above the score and "57" below the score. The other side is plain. They are supplied in bottles of 30 tablets (NDC 33261-0739-30). Store at 20°- 25°C (68°- 77°F) [See USP Controlled Room Temperature]. Protect from moisture. Keep out of reach of children.

Autorizācija statuss:

Abbreviated New Drug Application

Lietošanas instrukcija

KETOCONAZOLE- KETOCONAZOLE TABLET
Aidarex Pharmaceuticals LLC
----------
MEDICATION GUIDE
Ketoconazole Tablets USP, 200 mg
What is the most important information I should know about
ketoconazole tablets USP?
Ketoconazole tablets is not the only medicine available to treat
fungal infections and should only be used
when other medicines are not right for you. Talk to your healthcare
provider to find out if ketoconazole
tablets are right for you.
Ketoconazole tablets USP can cause serious side effects, including:
•
liver problems (hepatotoxicity). Some people who were treated with
ketoconazole the active
ingredient in ketoconazole tablets, had serious liver problems that
led to death or the need for a
liver transplant. Call your healthcare provider right away if you have
any of the following
symptoms:
•
loss of appetite or start losing weight (anorexia)
•
nausea or vomiting
•
feel tired
•
stomach pain or tenderness
•
dark urine or light colored stools
•
yellowing of your skin or the whites of your eyes
•
fever or rash
•
changes in the electrical activity of your heart called QT
prolongation. QT prolongation can cause
irregular heart beats that can be life threatening. This can happen
when ketoconazole tablets are
taken with certain medicines, such as dofetilide, quinidine, pimozide,
and cisapride. Talk to your
healthcare provider about other medicines you are taking before you
start taking ketoconazole
tablets. Tell your healthcare provider right away if you feel faint,
lightheaded, dizzy, or feel your
heart beating irregularly or fast. These may be symptoms related to QT
prolongation.
What are ketoconazole tablets USP?
•
Ketoconazole tablets are prescription medicine used to treat serious
fungal infections including:
blastomycosis, coccidioidomycosis, histoplasmosis, chromomycosis, and
paracoccidioidomycosis.
•
Ketoconazole tablets are not for people with fungal nail infections.
•
Ketoconazole tablets have not been approved for the treatment of
advanced prostate cancer or
Cushing's syndrome.

Produkta apraksts

KETOCONAZOLE- KETOCONAZOLE TABLET
AIDAREX PHARMACEUTICALS LLC
----------
KETOCONAZOLE
TABLETS USP,
200 MG
RX ONLY
WARNING
Ketoconazole tablets USP, 200 mg should be used only when other
effective antifungal therapy is
not available or tolerated and the potential benefits are considered
to outweigh the potential risks.
HEPATOTOXICITY
Serious hepatotoxicity, including cases with a fatal outcome or
requiring liver transplantation has
occurred with the use of oral ketoconazole. Some patients had no
obvious risk factors for liver
disease. Patients receiving this drug should be informed by the
physician of the risk and should be
closely monitored. See WARNINGS section.
QT PROLONGATION AND DRUG INTERACTIONS LEADING TO QT PROLONGATION
Co-administration of the following drugs with ketoconazole is
contraindicated: dofetilide,
quinidine, pimozide, cisapride. Ketoconazole can cause elevated plasma
concentrations of these
drugs and may prolong QT intervals, sometimes resulting in
life-threatening ventricular
dysrhythmias such as torsades de pointes. See CONTRAINDICATIONS,
WARNINGS, and
PRECAUTIONS: Drug Interactions sections.
DESCRIPTION
Ketoconazole tablets USP is a synthetic broad-spectrum antifungal
agent available in scored white
tablets, each containing 200 mg ketoconazole base for oral
administration. Inactive ingredients are
colloidal silicon dioxide, corn starch, lactose monohydrate, magnesium
stearate, microcrystalline
cellulose, and povidone. Ketoconazole is
cis-1-acetyl-4-[4-[[2-(2,4dichlorophenyl)-2-(1H-imidazol-1-
ylmethyl)-1,3-dioxolan-4-yl]methoxyl]phenyl] piperazine and has the
following structural formula:
Ketoconazole is a white to slightly beige, odorless powder, soluble in
acids, with a molecular weight
of 531.44.
CLINICAL PHARMACOLOGY
PHARMACOKINETICS
Mean peak plasma levels of approximately 3.5 µg/mL are reached within
1 to 2 hours, following oral
administration of a single 200 mg dose taken with a meal. Subsequent
plasma elimination is biphasic with
a half-life of 2 hours during the first 10 hours and